iC9-CAR.B7-H3 T cell therapy / UNC Lineberger Comprehensive Cancer Center, Bellicum - LARVOL DELTA

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells (clinicaltrials.gov) - P1 | N=42 | Recruiting | Sponsor: UNC Lineberger Comprehensive Cancer Center | Trial completion date: May 2028 ➔ May 2030 | Trial primary completion date: May 2026 ➔ May 2028

Trial completion date • Trial primary completion date • Breast Cancer • Hormone Receptor Negative Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • HER-2 • PGR

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells (clinicaltrials.gov) - P1 | N=27 | Recruiting | Sponsor: UNC Lineberger Comprehensive Cancer Center | Trial completion date: Mar 2026 ➔ Apr 2036 | Trial primary completion date: Mar 2026 ➔ Apr 2036

Platinum resistant • Trial completion date • Trial primary completion date • Epithelial Ovarian Cancer • Oncology • Ovarian Cancer • Solid Tumor

Autologous CAR-T Cells Targeting B7-H3 in PDAC (clinicaltrials.gov) - P1 | N=27 | Recruiting | Sponsor: UNC Lineberger Comprehensive Cancer Center | Trial completion date: Jun 2028 ➔ Apr 2030 | Trial primary completion date: Jun 2026 ➔ Apr 2028

IO biomarker • Trial completion date • Trial primary completion date • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor